Additional Study links Actos to Bladder Cancer

Posted on behalf of Phillips Law Group on Jul 18, 2012 in Defective Drug

More evidence has surfaced regarding Actos linking to bladder cancer. People with type 2 diabetes has already an increased risk of getting bladder cancer, the diabetes drug Actos may raise that risk even more.

The diabetes drug also known as pioglitazone, raises the chances of bladder cancer by about one-fifth, according to prior studies. However, the individual risk of getting bladder cancer still remains low.The drug has previously been linked to bladder cancer, according to a study published in May 31 in BMJ; taking Actos for two years can double your chances of developing bladder cancer.

Although it's unclear how Actos may raise the risk of bladder cancer, animal studies suggested that the drug could cause crystals to form that irritate the bladder which could possibly play a role in the development of bladder cancer.

In the current study, data have included 10 studies in the analysis that had more than 2.6 million people. From that group, 3,643 people were newly diagnosed with bladder cancer.

If you or a loved one has been diagnosed with bladder cancer after taking Actos you may be entitled to compensation. Contact the Phoenix Dangerous Drugs Lawyers at Phillips Law Group to explore your legal options.

To receive a free case review, fill out the contact form on this page.

Back to Top